Susan Molineaux
Slammed with PhII flop for lead drug, Calithera lays off a third of its staffers
Calithera Biosciences will be going into the new year with only two-thirds of its staff.
The South San Francisco-based biotech is laying off “around 30 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
